Pharmaceutical Technology

SEPTEMBER 8, 2022

Pharmaceutical solid dose manufacturing companies in contract marketing segment have gained a vital position in pharmaceutical formulations. Find the leading pharmaceutical solid dose manufacturing companies in contract marketing.

Manufacturing 100

Manufacturing Marketing Contract Manufacturing Containment 100

Pharmaceutical Technology

JULY 4, 2022

Russia is an already insular country and its worldview has tended to be self-contained, but this has hardened in the face of recent sanctions and counter-sanctions imposed during the war with Ukraine. Several global pharma companies have already withdrawn their support following Russia’s invasion of Ukraine, which began on 24 February.

Pharma Production 305

Pharma Production Production Clinical Trials Clinical Trials 305

Drug Discovery World

DECEMBER 14, 2023

The university contains the Medical Research Council (MRC)-University of Glasgow Centre for Virus Research (CVR), as well as CRUSH, part of CVR and established in partnership with LifeArc to address pandemic preparedness. For a growing company like BioAscent, there are huge advantages in being situated within a cluster.

Drugs 75

Drugs Life Science Research Scientist 75

Pharmaceutical Technology

APRIL 24, 2023

Biologics are costly to produce and sell, and the more recent modalities, such as cell and gene therapies, can be difficult to manufacture. With new drugs on the market, companies are now looking for ways to manufacture recently approved biologics, and countries are racing to claim their corner – or maintain their decades-old market share.

Contract Manufacturing 130

Contract Manufacturing Manufacturing Protein Sales 130

Pharmaceutical Technology

DECEMBER 6, 2022

Despite the current emphasis on biologic medicines, small molecule drugs still dominate the pharmaceutical manufacturing world. Manufacturing these highly potent and often cytotoxic drugs introduces many risks for operators and the environment. But containment is not only important at commercial-stage manufacturing.

Containment 130

Containment Development Drugs Contract Manufacturing 130

Pharmaceutical Technology

JUNE 14, 2023

This, coupled with small pharma companies being unable to acquire or access containment capabilities in-house, means that the demand for innovative specialized small molecule capabilities remains high. Of those, only 935 (34%) small molecule API facilities offered some type of containment capabilities.

Containment 130

Containment Manufacturing Contract Manufacturing Bioavailability 130